Paul J. Sekhri - 01 Aug 2022 Form 3 Insider Report for vTv Therapeutics Inc. (VTVT)

Role
President and CEO, Director
Signature
/s/ Paul J. Sekhri
Issuer symbol
VTVT
Transactions as of
01 Aug 2022
Transactions value $
$0
Form type
3
Filing time
08 Aug 2022, 20:20:41
Previous filing
13 Jun 2022
Next filing
06 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VTVT Employee stock option (right to buy) 01 Aug 2022 Class A Common Stock 2.2M $0.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options were granted as part of an inducement award. An option to purchase 550,000 shares vests on July 26, 2023, and the remaining option to purchase 1,650,000 shares vests in equal quarterly installments over the three-year period beginning on July 26, 2023, subject to continued employment (or earlier, upon achievement of certain performance measures).